160 related articles for article (PubMed ID: 1430412)
1. Topical mechlorethamine in the treatment of mycosis fungoides.
Silver SE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):786-7. PubMed ID: 1430412
[No Abstract] [Full Text] [Related]
2. Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
Vonderheid EC; Van Scott EJ
Cleve Clin Q; 1983; 50(2):97-100. PubMed ID: 6640944
[No Abstract] [Full Text] [Related]
3. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
Price NM
Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
[TBL] [Abstract][Full Text] [Related]
4. Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Querfeld C; Geskin LJ; Kim EJ; Scarisbrick JJ; Quaglino P; Papadavid E; Angello JT; Ortiz-Romero PL
J Invest Dermatol; 2021 Jun; 141(6):1601-1604.e2. PubMed ID: 33347924
[No Abstract] [Full Text] [Related]
5. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
6. Complete regressions of mycosis fungoides with topical mechlorethamine hydrochloride.
Van Scott EJ
JAMA; 1972 Nov; 222(9):1172. PubMed ID: 4678061
[No Abstract] [Full Text] [Related]
7. Topical chemotherapy in mycosis fungoides.
Grupper C; Durepaire R
Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
[No Abstract] [Full Text] [Related]
8. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
[No Abstract] [Full Text] [Related]
9. [Topical chemotherapy in mycosis fungoides (author's transl)].
Touraine R; Revuz J
Dermatologica; 1978; 157(6):397-406. PubMed ID: 363476
[No Abstract] [Full Text] [Related]
10. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
11. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
du Vivier A; Vollum DI
Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
[TBL] [Abstract][Full Text] [Related]
12. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
13. Topical mechlorethamine in the treatment of mycosis fungoides. Uniformity of application and potential for environmental contamination.
Breneman DL; Nartker AL; Ballman EA; Pruemer JM; Blumsack RF; Davis M; Breneman JC
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1059-64. PubMed ID: 1844356
[TBL] [Abstract][Full Text] [Related]
14. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
15. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
Liner K; Brown C; McGirt LY
Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
[TBL] [Abstract][Full Text] [Related]
16. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
Kim EJ; Geskin L; Guitart J; Querfeld C; Girardi M; Musiek A; Mink DR; Williams MJ; Angello JT; Bailey WL
J Am Acad Dermatol; 2020 Sep; 83(3):928-930. PubMed ID: 32089294
[No Abstract] [Full Text] [Related]
17. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
Vonderheid EC
Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
[No Abstract] [Full Text] [Related]
18. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
19. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
Hamminga B; Noordijk EM; van Vloten WA
Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
